Skip to main content
. 2020 Apr 20;10:6573. doi: 10.1038/s41598-020-63611-6

Figure 4.

Figure 4

Erythrocyte binding assay for PfRipr. (a) PfRipr-HA localizati on. Paraformaldehyde-fixed mature schizonts from PfRipr-HA transfected P. falciparum were probed with rabbit anti-HA antibody (Ripr-HA: green) and co-stained with mouse antibodies to AMA1, a microneme marker (AMA1: red). The parasite nuclei were stained with DAPI (DAPI: blue). DIC; differential interference contrast. Scale bar = 3 µm. (b) Detection of PfRipr-HA in culture supernatant of PfRipr-HA transfected parasites. Culture supernatant was examined by Western blotting under reducing conditions with rabbit anti-HA antibodies. M: molecular weight marker. (c,d) Erythrocyte binding activity of PfRipr protein probed with anti-HA antibody (c) and EBA175 protein probed with anti-EBA175 antibody (d) obtained from parasite culture supernatant. I, parasite culture supernatant; U, untreated erythrocytes; N, neuraminidase treated erythrocytes; T, trypsin treated erythrocytes; C, chymotrypsin treated erythrocytes. M: molecular weight marker. (e,f) Erythrocyte binding activity of recombinant (e) PfRipr protein and (f) His-GST. I, recombinant protein; U, untreated erythrocytes; N, neuraminidase treated erythrocytes; T, trypsin treated erythrocytes; C, chymotrypsin treated erythrocytes. M: molecular weight marker. (g) GIA activity of recombinant proteins. Purified recombinant GST-fused PfRipr and in vitro cultured P. falciparum 3D7 strain. His-GST protein was used as a negative control. Error bar represents standard error of the mean. * Indicates statistically significant (Kruskal-Wallis test; P < 0.05) when compared to His-GST protein.